National Health Investors, Inc. (NYSE: NHI) Stock Analysis & Fundamentals

NHINational Health Investors, Inc.

NYSE · US · Real Estate · REIT - Healthcare Facilities · nhireit.com

79.14USD+4.35%Mkt Cap: 3.84B $P/E: 25.531d ago

National Health Investors, Inc. is a self-managed real estate investment trust specializing in sale-leaseback, joint venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical f…

Industry Peers

REIT - Healthcare Facilities

Omega Healthcare Investors, Inc.

$15.55BUSDP/E 24.1

DOC

Healthpeak Properties, Inc.

Healthcare Realty Trust Incorporated

Chartwell Retirement Residences

$5.42BUSDP/E Infinity

SBRA

Sabra Health Care REIT, Inc.

$5.08BUSDP/E 32.0

MPT

Medical Properties Trust, Inc.

$2.88BUSD

PHP

Primary Health Properties Plc

$2.66BUSDP/E 13.5

DHC

Diversified Healthcare Trust

National Healthcare Properties, Inc.

$1.15BUSD

CPINV

Care Property Invest NV

$581.71MUSDP/E 8.3

UHT

Universal Health Realty Income Trust

$607.75MUSDP/E 34.2

XRN

Chiron Real Estate Inc.

$598.43MUSD

CHCT

Community Healthcare Trust Incorporated

$530.86MUSDP/E 154.8

STRW

Strawberry Fields REIT, Inc.

$184.88MUSDP/E 21.5

Indicators:|

Key Statistics

Company

Market Cap3.84B $

Enterprise Value5.26B $

Revenue (TTM)404.71M $

Gross Profit364.65M $

Net Income (TTM)142.18M $

Revenue/Share8.516 USD

Last Price79.14 USD

Fiscal Year EndDec 2025

MR QuarterMar 2021

Employees32

CountryUS

SectorReal Estate

IndustryREIT - Healthcare Facilities

ISINUS63633D1046

Valuation

P/E (Trailing)25.53

P/E (Forward)22.94

PEG4.76

EV/EBITDA18.44

EV/Revenue12.99

P/S9.48

P/B2.53

EPS (TTM)3.10

EPS (Forward)3.45

52W Range

67.9548% of range91.38

52W High91.38 USD

52W Low67.95 USD

Profitability

Gross Margin97.08%

Oper. Margin61.34%

EBITDA Margin70.46%

Profit Margin37.85%

ROE9.34%

ROA5.08%

Growth

Revenue Growth-2.60%

Earnings Growth-43.00%

Cash Flow & Leverage

Operating CF236.56M $

CapEx (TTM)—

FCF Margin51.38%

FCF Yield5.42%

Net Debt1.41B $

Net Debt/EBITDA4.95

Balance Sheet

Debt/Equity0.76

Current Ratio0.60

Quick Ratio0.55

Book Value/Sh31.26 USD

Cash/Share2.339 USD

Dividends

Fwd Div Rate3.680 USD

Trail. Div Rate3.660 USD

Div. Yield4.85%

5Y Avg Yield5.85%

Payout Ratio118.06%

Ex-Div DateJun 30, 2026

Pay DateAug 7, 2026

Analyst Consensus

Rating1.8 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)82.88 USD

Upside (mean)+4.7%

Target Range74.00 USD – 91.00 USD

$74.00+4.7% to mean$91.00

# Analysts8

Ownership

Shares Out.48.47M

Float47.30M

Insiders2.42%

Institutions75.78%

Short Interest

Short Ratio3.9d

Short % Float7.91%

Short % Out.7.72%

Shares Short3.74M

Short (prev mo.)2.13M

Technical

SMA 5074.29 (+6.5%)

SMA 20078.68 (+0.6%)

Beta0.54

S&P 52W Chg19.63%

Avg Vol (30d)433.15K

Avg Vol (10d)429.65K

Technical Indicators

RSI (14)63.7

MACD0.8364

MACD Signal0.6438

MACD Hist.+0.1925

BB Upper80.30 USD

BB Middle75.55 USD

BB Lower70.79 USD

BB Width12.59%

ATR (14)1.806 USD

Vol Ratio (20d)0.57x